New Zealand researchers have discovered a telltale marker left in the brain after a concussion – potentially giving doctors a ...

New Zealand researchers have discovered a telltale marker left in the brain after a concussion – potentially giving doctors a clearer steer on when to stand down players. Around 33,250 cases of mild ...

Having a better midlife diet associated with better functional connectivity between the hippocampus and both the occipital ...

A preclinical study from Northeastern University has revealed astonishing evidence that psilocybin – the psychedelic compound ...

Leydig cell tumours (LCT) are rare sex-cord gonadal tumours that account for less than 5% of testicular neoplasms. They are ...

Using a novel quantitative chemoproteomic strategy, a research group led by Prof. Wang Chu from the College of Chemistry and ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's diseaseSimufilam continued to dem ...

Jan. 15, 2025 — Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be ...

Enigma Biomedical USA Inc. has selected two four-repeat tau (4R tau) protein PET imaging biomarkers to advance into phase I studies. These imaging biomarkers show promise as important new tools in ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...